NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, announced today it has received an Israeli Patent for its Ultrapure Transferrin to be used in Pharmaceutical Compositions. This is the second patent issued to Kamada under the same title after being granted with the same patent title by the United States Patent Office (USPTO).
